Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
AstraZeneca Community
NasdaqGS:AZN Community
1
Narratives
written by author
0
Comments
on narratives written by author
50
Fair Values set
on narratives written by author
Create a narrative
Community Investing Ideas
AstraZeneca
Popular
Undervalued
Overvalued
AstraZeneca
NA
NateF
Community Contributor
AZN Market Outlook
AstraZeneca PLC (AZN) is a prominent player in the pharmaceutical industry, with a diverse portfolio and a strong focus on innovation. Has recently demonstrated robust financial performance, with notable developments that may influence its market position over the next 1-3 years.
View narrative
US$130.22
FV
42.8% undervalued
intrinsic discount
6.26%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
7 months ago
author updated this narrative
Your Valuation for
AZN
AZN
AstraZeneca
Your Fair Value
US$
Current Price
US$74.48
46.5% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-1b
75b
2015
2018
2021
2024
2025
2027
2030
Revenue US$74.7b
Earnings US$11.0b
Advanced
Set Fair Value